The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cellular and Molecular Mechanisms of Coronary Artery Spasm: - Lessons From Animal Models -
Open accessAbstract
Coronary artery spasm plays an important role in the pathogenesis of a wide variety of ischemic heart diseases, especially in the Japanese population. Because coronary artery spasm can be induced by a variety of stimuli with different mechanisms of action, the occurrence of the spasm appears to be due to the local hyperreactivity of the coronary artery rather than to an enhanced stimulation with a single mechanism of action. Several lines of evidence indicate that coronary artery spasm is caused primarily by smooth muscle hypercontraction whereas the contribution of endothelial dysfunction may be minimal. In order to elucidate the cellular and molecular mechanisms of the spasm, porcine models of the spasm were developed. In the first model with balloon injury and high-cholesterol feeding, a close topological correlation between the early atherosclerotic lesions and the spastic sites was noted, whereas in the second model with an inflammatory cytokine the potential importance of coronary inflammatory changes, especially at the adventitia, was noted. Subsequent studies in vivo and in vitro demonstrated that protein kinase C (PKC) and Rho-kinase are substantially involved in the intracellular mechanism of the spasm, resulting in increases in the mono- and diphosphorylations of myosin light chain (MLC). Furthermore, molecular biological analyses demonstrated that Rho-kinase is upregulated at the spastic site (at all levels, including mRNA, protein, and activity), resulting in the inhibition of MLC phosphatase through the phosphorylation of its myosin binding subunit and thereby causing the increase in MLC phosphorylations. Preliminary results also suggest that the long-term inhibition of Rho-kinase is effective in inhibiting the development of arteriosclerotic vascular lesions in several porcine models. Thus, Rho-kinase could be regarded as a novel therapeutic target for coronary arteriosclerosis in general and coronary artery spasm in particular.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inositol trisphosphate and calcium signalling
Berridge, M. J. (1993) · Nature · doi:10.1038/361315a0 · Cited by 6,545
Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase
Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N., Matsuura, Y., & Kaibuchi, K. (1997) · Science · doi:10.1126/science.275.5304.1308 · Cited by 1,077
Cocaine-Induced Coronary-Artery Vasoconstriction
Lange, R. A., Cigarroa, R. G., Yancy, C. W., Willard, J. E., Popma, J. J., Sills, M. N., McBride, W., Kim, A. S., & Hillis, L. D. (1989) · New England Journal of Medicine · doi:10.1056/nejm198912073212301 · Cited by 619
Cited by
Fukata, Y., Kaibuchi, K., Amano, M., & Kaibuchi, K. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01596-0 · Cited by 750
Rho-Kinase Is an Important Therapeutic Target in Cardiovascular Medicine
Shimokawa, H., & Takeshita, A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000176193.83629.c8 · Cited by 480
Self-citationRhoA/Rho-Kinase in the Cardiovascular System
Shimokawa, H., Sunamura, S., & Satoh, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306532 · Cited by 461
Self-citationMasumoto, A., Mohri, M., Shimokawa, H., Urakami, L., Usui, M., & Takeshita, A. (2002) · Circulation · doi:10.1161/hc1002.105938 · Cited by 452
Self-citationOnuma, Y., & Serruys, P. W. (2011) · Circulation · doi:10.1161/circulationaha.110.971606 · Cited by 434
Higashi, M., Shimokawa, H., Hattori, T., Hiroki, J., Mukai, Y., Morikawa, K., Ichiki, T., Takahashi, S., & Takeshita, A. (2003) · Circulation Research · doi:10.1161/01.res.0000096650.91688.28 · Cited by 418
Self-citationMing, X.-F., Viswambharan, H., Barandier, C., Ruffieux, J., Kaibuchi, K., Rusconi, S., & Yang, Z. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8467-8477.2002 · Cited by 402
Coronary artery spasm—Clinical features, diagnosis, pathogenesis, and treatment
Yasue, H., Nakagawa, H., Itoh, T., Harada, E., & Mizuno, Y. (2008) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.01.001 · Cited by 397
Rho/Rho-kinase mediated signaling in physiology and pathophysiology
Wettschureck, N., & Offermanns, S. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0370-2 · Cited by 334
Invited Review: Regulation of myosin phosphorylation in smooth muscle
Pfitzer, G. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.1.497 · Cited by 315
Possible Involvement of Rho-Kinase in the Pathogenesis of Hypertension in Humans
Masumoto, A., Hirooka, Y., Shimokawa, H., Hironaga, K., Setoguchi, S., & Takeshita, A. (2001) · Hypertension · doi:10.1161/hy1201.096541 · Cited by 307
Self-citationRho-kinase: important new therapeutic target in cardiovascular diseases
Satoh, K., Fukumoto, Y., & Shimokawa, H. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00327.2011 · Cited by 282
Self-citationShibuya, M., Hirai, S., Seto, M., Satoh, S.-I., & Ohtomo, E. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.06.003 · Cited by 275
Rho-kinase as a Novel Therapeutic Target in Treatment of Cardiovascular Diseases
Shimokawa, H. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200203000-00001 · Cited by 262
Self-citation
Metadata
- Authors
- Shimokawa, H.
- Venue
- Japanese Circulation Journal
- Publisher
- Japanese Circulation Society
- Published
- 2000
- Volume
- 64
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0047-1828 (ISSN-L)
- 1347-4839
- OpenAlex
- W1789713350
- Cited by
- 171
- References
- 3
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.